Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

The burden of invasive pneumococcal disease and the potential for reduction by immunisation.

Parsons HK, Dockrell DH.

Int J Antimicrob Agents. 2002 Feb;19(2):85-93. Review.

PMID:
11850160
2.
3.

The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.

Isaacman DJ, Strutton DR, Kalpas EA, Horowicz-Mehler N, Stern LS, Casciano R, Ciuryla V.

Clin Ther. 2008 Feb;30(2):341-57. doi: 10.1016/j.clinthera.2008.02.003. Review.

PMID:
18343273
4.
5.
6.

Streptococcus pneumoniae: does antimicrobial resistance matter?

Lynch JP 3rd, Zhanel GG.

Semin Respir Crit Care Med. 2009 Apr;30(2):210-38. doi: 10.1055/s-0029-1202939. Epub 2009 Mar 18. Review.

PMID:
19296420
7.

Streptococcus pneumoniae: epidemiology, risk factors, and clinical features.

Ortqvist A, Hedlund J, Kalin M.

Semin Respir Crit Care Med. 2005 Dec;26(6):563-74. Review.

PMID:
16388428
8.

[The elderly should be vaccinated against pneumococci].

Ortqvist A, Hedlund J, Kalin M.

Lakartidningen. 1999 Mar 17;96(11):1305-8. Review. Swedish.

PMID:
10194909
9.

The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use.

Toltzis P, Jacobs MR.

Infect Dis Clin North Am. 2005 Sep;19(3):629-45. Review.

PMID:
16102653
10.

Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.

Dagan R.

Clin Microbiol Infect. 2009 Apr;15 Suppl 3:16-20. doi: 10.1111/j.1469-0691.2009.02726.x. Review.

11.

Cost-effectiveness of pneumococcal polysaccharide vaccination in adults: a systematic review of conclusions and assumptions.

Ogilvie I, Khoury AE, Cui Y, Dasbach E, Grabenstein JD, Goetghebeur M.

Vaccine. 2009 Aug 6;27(36):4891-904. doi: 10.1016/j.vaccine.2009.05.061. Epub 2009 Jun 9. Review.

PMID:
19520205
12.

Pneumococcal vaccine in the elderly: a useful but forgotten vaccine.

Chidiac C, Ader F.

Aging Clin Exp Res. 2009 Jun;21(3):222-8. Review.

PMID:
19571646
13.

Drug treatment of pneumococcal pneumonia in the elderly.

Neralla S, Meyer KC.

Drugs Aging. 2004;21(13):851-64. Review.

PMID:
15493950
14.

The potential indirect effect of conjugate pneumococcal vaccines.

O'Brien KL, Dagan R.

Vaccine. 2003 May 16;21(17-18):1815-25. Review.

PMID:
12706665
15.

Penicillin resistance and serotyping of Streptococcus pneumoniae in Latin America.

Camargos P, Fischer GB, Mocelin H, Dias C, Ruvinsky R.

Paediatr Respir Rev. 2006 Sep;7(3):209-14. Epub 2006 Aug 8. Review.

PMID:
16938644
16.

Lessons learned from clinical trials evaluating pneumococcal conjugate vaccine efficacy against pneumonia and invasive disease.

Madhi SA, Whitney CG, Nohynek H.

Vaccine. 2008 Jun 16;26 Suppl 2:B9-B15. doi: 10.1016/j.vaccine.2008.06.001. Review.

PMID:
18793605
17.

Pneumococcal vaccination.

Williams RM.

Lippincotts Prim Care Pract. 1998 Nov-Dec;2(6):625-33. Review.

PMID:
9883157
18.

An evaluation of emerging vaccines for childhood pneumococcal pneumonia.

Webster J, Theodoratou E, Nair H, Seong AC, Zgaga L, Huda T, Johnson HL, Madhi S, Rubens C, Zhang JS, El Arifeen S, Krause R, Jacobs TA, Brooks AW, Campbell H, Rudan I.

BMC Public Health. 2011 Apr 13;11 Suppl 3:S26. doi: 10.1186/1471-2458-11-S3-S26. Review.

19.

The transforming Streptococcus pneumoniae in the 21st century.

Hsieh YC, Lee WS, Shao PL, Chang LY, Huang LM.

Chang Gung Med J. 2008 Mar-Apr;31(2):117-24. Review.

20.

Impact of pneumococcal conjugate vaccine on the prevention of invasive pneumococcal diseases.

Bricks LF, Berezin E.

J Pediatr (Rio J). 2006 Jul;82(3 Suppl):S67-74. Epub 2006 May 19. Review.

Supplemental Content

Support Center